Back to today’s briefing

Story perspectives

AI-Driven Saliva Test Predicts Cancer Treatment Risks

4/22/2025

50 9

Summary

Story summary

Virginia Tech researchers have harnessed the power of AI to create a groundbreaking saliva test that identifies cancer patients at risk of severe side effects from the chemotherapy drug 5-fluorouracil (5-FU). By targeting genetic mutations that influence drug metabolism, this innovative test seeks to tailor treatments and minimize complications. Exciting early results were shared at the 2025 ASCO Gastrointestinal Cancers Symposium.

1 of 1

Story summary

Virginia Tech researchers have harnessed the power of AI to create a groundbreaking saliva test that identifies cancer patients at risk of severe side effects from the chemotherapy drug 5-fluorouracil (5-FU). By targeting genetic mutations that influence drug metabolism, this innovative test seeks to tailor treatments and minimize complications. Exciting early results were shared at the 2025 ASCO Gastrointestinal Cancers Symposium.